Practical Syntheses of Sphingosine-1-Phosphate
and Analogues

Virginie Blot; Ulrich Jacquemard; Hans-Ulrich Reissig; Burkhard Kleuser

doi:10.1055/s-0028-1083373

PAPER

Practical Syntheses of Sphingosine-1-Phosphate and Analogues

Virginie Blot^a, Ulrich Jacquemard^a, Hans-Ulrich Reissig*^a, Burkhard Kleuser^b
^a Institut für Chemie und Biochemie, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany
Fax: +49(30)83855367; e-Mail: hans.reissig@chemie.fu-berlin.de ;
^b Institut für Pharmazie, Freie Universität Berlin, Königin-Luise Str. 2-4, 14195 Berlin, Germany

Abstract

All articles of this category

Abstract

Sphingosine-1-phosphate (S1P, 1) is a bioactive sphingolipid metabolite involved in a variety of critical cellular processes including proliferation, survival, and migration. For this reason the stereoselective syntheses of S1P and analogues are of great interest. Based on l-serine as source of chirality we achieved practical routes to prepare S1P (1) and the aryl group containing analogues 3 and 4 in fair amounts. The crucial stages of the syntheses are: introduction of the required side chain by addition of appropriate organometallics to Garner’s aldehyde and conversion of the primary alcohols into the corresponding phosphates.

Key words

phosphates - amino alcohols - lipids - organometallic reagents - sphingosine derivatives

Full Text

References

1 Ishii I. Fukushima N. Ye X. Chun J. Annu. Rev. Biochem. 2004, 73: 321

2 Lim HS. Park JJ. Ko K. Lee MH. Chung SK. Bioorg. Med. Chem. Lett. 2004, 14: 2499

3 Takabe K. Paugh SW. Milstien S. Spiegel S. Pharmacol. Rev. 2008, 60: 181

4 Tarnowski A. Retz O. Bär T. Schmidt RR. Eur. J. Org. Chem. 2005, 1129

For recent reviews on chemistry and biology of sphingosine derivatives, see:

5a Liao J. Tao J. Lin G. Liu D. Tetrahedron 2005, 61: 4715

5b Koskinen PM. Koskinen AMP. Synthesis 1998, 1075

For publications on the synthesis of d-(2S,3R)-sphingosine and references cited, see:

6a Merino P. Jimenez P. Tejero T. J. Org. Chem. 2006, 71: 4685

6b Kim S. Lee S. Ko H. Kim D. J. Org. Chem. 2006, 71: 8661

6c Yamamoto T. Hasegawa H. Hakogi T. Katsumura S. Org. Lett. 2006, 8: 5569

6d Yang H. Liebeskind LS. Org. Lett. 2007, 9: 2993

For selected publications on recent synthesis of sphingosine analogues, see:

7a Grijalvo S. Llebaria A. Delgado A. Synth. Commun. 2007, 37: 2737

7b Kim S. Lee YM. Kang HR. Cho J. Lee T. Kim D. Org. Lett. 2007, 9: 2127 ; and references cited therein

For other syntheses of sphingosine using l-serine, see:

8a Radunz HE. Devant RM. Eiermann V. Liebigs Ann. Chem. 1988, 1103

8b Herold P. Helv. Chim. Acta 1988, 71: 354

8c Garner P. Park JM. Malecki E. J. Org. Chem. 1988, 53: 4395

8d Nimkar S. Menaldino D. Merrill AH. Liotta D. Tetrahedron Lett. 1988, 29: 3037

8e Soai K. Takahashi K. J. Chem. Soc., Perkin Trans. 1 1994, 1257

8f Azuma H. Tamagaki S. Ogino K. J. Org. Chem. 2000, 65: 3538

8g Murakami T. Furusawa K. Tetrahedron 2002, 58: 9257

8h Chun J. Li G. Byun H.-S. Bittman R. Tetrahedron Lett. 2002, 43: 375

8i Suzuki H. Mori M. Shibakami M. Synlett 2003, 2163

8j Sawatzki P. Kolter T. Eur. J. Org. Chem. 2004, 3693

8k Murakami T. Furusawa K. Tamai T. Yoshikai K. Nishikawa M. Bioorg. Chem. Med. Lett. 2005, 15: 1115

8l Okamoto N. Kanie O. Huang Y.-Y. Fujii R. Watanabe H. Shimamura M. Chem. Biol. 2005, 12: 677

8m

Reference 6c.

8n Ohshita K. Ishiyama H. Takahashi Y. Ito J. Mikami Y. Kobayashi J. Bioorg. Med. Chem. 2007, 15: 4910

9 For reviews concerning Garner’s aldehyde, see: Liang X. Andersch J. Bols M. J. Chem. Soc., Perkin Trans. 1 2001, 2136

10a Dondoni A. Perrone D. Synthesis 1997, 527

10b Williams L. Zhang Z. Shao F. Carroll PJ. Joullié MM. Tetrahedron 1996, 52: 11673

10c Yonezawa Y. Shimizu K. Yoon K.-S. Shin C.-G. Synthesis 2000, 634

11 Chun J. He LL. Byun HS. Bittman R. J. Org. Chem. 2000, 65: 7634

12 Review on ionic hydrogenations: Kursanov DN. Parnes ZN. Loim MM. Synthesis 1974, 633

Selected applications of ionic hydrogenations:

13a Kraus GA. Frazier KA. Roth BD. Taschner MJ. Neuenschwander K. J. Org. Chem. 1981, 46: 2417

13b Kraus GA. Molina MT. Walling JA. J. Org. Chem. 1987, 52: 1273

13c Badirad SA. Wang Y. Kishi Y. J. Org. Chem. 1987, 52: 1370

13d Brückner C. Holzinger H. Reissig H.-U. J. Org. Chem. 1988, 53: 2450

13e Arndt S. Emde U. Bäurle S. Friedrich T. Grubert L. Koert U. Chem. Eur. J. 2001, 7: 993

14 Szulc ZM. Hannun YA. Bielawska A. Tetrahedron Lett. 2000, 41: 7821

15 Oza VB. Corcoran RC. J. Org. Chem. 1995, 60: 3680

16a Lim HS. Oh YS. Suh PG. Chung SK. Bioorg. Med. Chem. Lett. 2003, 13: 237

16b Kratzer B. Schmidt RR. Tetrahedron Lett. 1993, 34: 1761

17

The scaling-up, essentially following our protocol, provided S1P 1 in quantities of more than 100 g.